Bright Ferritin for Non‐Invasive MRI Monitoring of the Fate of Transplanted hPSC ‐Cardiomyocytes in the Infarcted Rat Heart
Magnetic Resonance in Medicine · 2026-07 · 96 (1) · 323-338
DOI: 10.1002/mrm.70316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, online erschienen am 26.02.2026. Verfasst von Keyu Zhuang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Myocytes, Cardiac, Myocardial Infarction, Ferritins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canada First Research Excellence Fund, Government of Canada's New Frontiers in Research Fund, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Purpose
To demonstrate that a recently reported bright ferritin magnetic resonance imaging (MRI) platform can track transplanted human pluripotent stem cell (hPSC)‐derived cardiomyocytes (hPSC‐CMs) longitudinally and on‐demand in the rat heart.
Methods
Ferritin‐overexpressing hPSCs were differentiated into cardiomyocytes and assessed for cell viability, contractile functional proteins, and electrophysiological properties in vitro. In an immunodeficient rat model, hPSC‐CMs injected into the left ventricular myocardium were tracked on cardiac MRI at 3 Tesla over 8 weeks in both healthy and infarcted hearts. Longitudinal MRI was accompanied by MnCl 2 supplementation for on‐demand recall of bright signal from ferritin‐overexpressing hPSC‐CMs. MRI findings were corroborated against histological validation.
Results
Ferritin‐overexpressing hPSC‐CMs displayed normal morphological and functional phenotypes and created viable grafts in vivo. On‐demand recall of bright contrast on MRI was achieved, regardless of interval post‐cell transplantation, via MnCl 2 administration to precisely map surviving hPSC‐CMs in both healthy and infarcted hearts. The spatial distribution of hPSC‐CMs on MRI was confirmed throughout the heart by histology. Echocardiography confirmed MnCl 2 had no impact on cardiac function, although in vitro tests revealed transiently dampened calcium handling and contractility, an effect from which cells fully recovered after removing MnCl 2 .
Conclusion
Bright ferritin MRI allows longitudinal, non‐invasive, and on‐demand imaging of the distribution of viable transplanted hPSC‐CMs in the healthy and infarcted rat heart.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
- Translational Biology & Engineering Program, Ted Rogers Centre for Heart Research, Toronto, Ontario, Canada.
- McEwen Stem Cell Institute, University Health Network, Toronto, Ontario, Canada.
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
- Department of Biology, University of Toronto Mississauga, Mississauga, Ontario, Canada.
- Department of Cell and Systems Biology, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Keyu Zhuang, Faisal J Alibhai, Beiping Qiang, Kyle D W Vollett, Bradley K C Freeman, Tameshwar Ganesh, Yu-Qing Zhou, Hai-Ying Mary Cheng, Michael A Laflamme, Hai-Ling Margaret Cheng
Förderung
- Canada First Research Excellence Fund
- Government of Canada's New Frontiers in Research Fund
- Natural Sciences and Engineering Research Council of Canada
- Canada Foundation for Innovation
- Dean's Spark Professorship, University of Toronto
- Canada Excellence Research Chairs, Government of Canada
- Vanier (CIHR) Doctoral Scholarship
- Ted Rogers Centre for Heart Research
Zitieren
APA
Zhuang, K., Alibhai, F. J., Qiang, B., Romagnuolo, R., Vollett, K. D. W., Freeman, B. K. C., Gomez-Garcia, M. J., Sadikov Valdman, T., Ganesh, T., Zhou, Y. Q., Cheng, H. M., Laflamme, M. A., & Cheng, H. M. (2026). Bright Ferritin for Non‐Invasive MRI Monitoring of the Fate of Transplanted hPSC ‐Cardiomyocytes in the Infarcted Rat Heart. Magnetic Resonance in Medicine, 96(1), 323-338. https://doi.org/10.1002/mrm.70316
Vancouver
Zhuang K, Alibhai FJ, Qiang B, Romagnuolo R, Vollett KDW, Freeman BKC, et al. Bright Ferritin for Non‐Invasive MRI Monitoring of the Fate of Transplanted hPSC ‐Cardiomyocytes in the Infarcted Rat Heart. Magnetic Resonance in Medicine. 2026;96(1):323-338. doi:10.1002/mrm.70316
BibTeX
@article{Zhuang2026,
author = {Zhuang, Keyu and Alibhai, Faisal J and Qiang, Beiping and Romagnuolo, Rocco and Vollett, Kyle D W and Freeman, Bradley K C and Gomez-Garcia, M Juliana and Sadikov Valdman, Tamilla and Ganesh, Tameshwar and Zhou, Yu-Qing and Cheng, Hai-Ying Mary and Laflamme, Michael A and Cheng, Hai-Ling Margaret},
title = {Bright Ferritin for Non‐Invasive MRI Monitoring of the Fate of Transplanted hPSC ‐Cardiomyocytes in the Infarcted Rat Heart},
journal = {Magnetic Resonance in Medicine},
year = {2026},
volume = {96},
number = {1},
pages = {323--338},
doi = {10.1002/mrm.70316}
}
EUVIMED